Well, weight loss patients have five chief complaints: Tolerability - GLP-1s can induce GI side-effects, like nausea and vomiting Durability - once GLP-1 therapy is discontinued, patients regain weight Frequency - most GLP-1s are administered sub-cutaneously every week Access - Medicare, Medicaid, and most commercial insurers dont cover GLP-1s for weight loss
This study reveals that H 2 O 2 mediated oxidation of the mitochondrial glutathione pool by peroxiredoxin Prx1 is a key determinant of peroxideinduced cell death in yeast
Saliva is the mouths primary defence system
What Phase 2 Data Tells Us to Expect The Phase 2 trial of retatrutide, published in The New England Journal of Medicine in 2023, provided an unusually clear preview of what TRIUMPH-1 might deliver
[2] [7] Risk stratification using FIB-4 in primary care, with second-line tests such as the Enhanced Liver Fibrosis (ELF) test or transient elastography when indicated, helps identify those who may need specialist referral
